China
· Delayed Price · Currency is CNY Jiang Zhong Pharmaceutical Co.,Ltd Statistics
Total Valuation
Jiang Zhong Pharmaceutical Co.,Ltd has a market cap or net worth of CNY 13.92 billion. The enterprise value is 13.37 billion.
| Market Cap | 13.92B |
| Enterprise Value | 13.37B |
Important Dates
The next estimated earnings date is Monday, October 28, 2024.
| Earnings Date | Oct 28, 2024 |
| Ex-Dividend Date | Oct 10, 2024 |
Share Statistics
Jiang Zhong Pharmaceutical Co.,Ltd has 622.83 million shares outstanding. The number of shares has increased by 1.22% in one year.
| Shares Outstanding | 622.83M |
| Shares Change (YoY) | +1.22% |
| Shares Change (QoQ) | +2.00% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 17.84% |
| Float | 347.65M |
Valuation Ratios
The trailing PE ratio is 18.94 and the forward PE ratio is 16.43.
| PE Ratio | 18.94 |
| Forward PE | 16.43 |
| PS Ratio | 3.37 |
| PB Ratio | 3.64 |
| P/FCF Ratio | 18.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.73, with an EV/FCF ratio of 17.40.
| EV / Earnings | 17.89 |
| EV / Sales | 3.18 |
| EV / EBITDA | 13.73 |
| EV / EBIT | 15.72 |
| EV / FCF | 17.40 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.00.
| Current Ratio | 1.42 |
| Quick Ratio | 1.12 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.00 |
| Interest Coverage | 221.71 |
Financial Efficiency
Return on equity (ROE) is 18.00% and return on invested capital (ROIC) is 11.74%.
| Return on Equity (ROE) | 18.00% |
| Return on Assets (ROA) | 8.63% |
| Return on Capital (ROIC) | 11.74% |
| Revenue Per Employee | 1.05M |
| Profits Per Employee | 186,207 |
| Employee Count | 4,013 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 3.69 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.12% in the last 52 weeks. The beta is 0.31, so Jiang Zhong Pharmaceutical Co.,Ltd's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | +23.12% |
| 50-Day Moving Average | 21.48 |
| 200-Day Moving Average | 23.18 |
| Relative Strength Index (RSI) | 57.20 |
| Average Volume (20 Days) | 10,259,229 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Jiang Zhong Pharmaceutical Co.,Ltd had revenue of CNY 4.20 billion and earned 747.25 million in profits. Earnings per share was 1.18.
| Revenue | 4.20B |
| Gross Profit | 2.77B |
| Operating Income | 850.47M |
| Pretax Income | 951.68M |
| Net Income | 747.25M |
| EBITDA | 971.92M |
| EBIT | 850.47M |
| Earnings Per Share (EPS) | 1.18 |
Balance Sheet
The company has 1.15 billion in cash and 2.09 million in debt, giving a net cash position of 1.14 billion or 1.84 per share.
| Cash & Cash Equivalents | 1.15B |
| Total Debt | 2.09M |
| Net Cash | 1.14B |
| Net Cash Per Share | 1.84 |
| Equity (Book Value) | 4.48B |
| Book Value Per Share | 6.14 |
| Working Capital | 663.92M |
Cash Flow
In the last 12 months, operating cash flow was 971.08 million and capital expenditures -203.01 million, giving a free cash flow of 768.07 million.
| Operating Cash Flow | 971.08M |
| Capital Expenditures | -203.01M |
| Free Cash Flow | 768.07M |
| FCF Per Share | 1.23 |
Margins
Gross margin is 65.91%, with operating and profit margins of 20.25% and 17.79%.
| Gross Margin | 65.91% |
| Operating Margin | 20.25% |
| Pretax Margin | 22.66% |
| Profit Margin | 17.79% |
| EBITDA Margin | 23.14% |
| EBIT Margin | 20.25% |
| FCF Margin | 18.28% |
Dividends & Yields
This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 5.27%.
| Dividend Per Share | 1.20 |
| Dividend Yield | 5.27% |
| Dividend Growth (YoY) | 13.04% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 111.99% |
| Buyback Yield | -1.22% |
| Shareholder Yield | 4.05% |
| Earnings Yield | 5.28% |
| FCF Yield | 5.52% |
Stock Splits
The last stock split was on June 12, 2020. It was a forward split with a ratio of 1.2.
| Last Split Date | Jun 12, 2020 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Jiang Zhong Pharmaceutical Co.,Ltd has an Altman Z-Score of 6.82.
| Altman Z-Score | 6.82 |
| Piotroski F-Score | n/a |